{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:09:16Z","timestamp":1758197356465,"version":"3.44.0"},"reference-count":49,"publisher":"The Company of Biologists","issue":"10","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Erasmus Universiteit Rotterdam"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Craniosynostosis is a multigenic congenital condition in which one or more calvarial sutures have prematurely fused during the development of the fetus. Pathogenic variants in FGFR2 are associated with the development of syndromic craniosynostosis, such as Crouzon, Apert and Pfeifer syndromes. Investigation of FGFR2-linked craniosynostosis is hindered by the lack of appropriate in vitro models. Patient-derived human induced pluripotent stem cell (hiPSC) in vitro disease models provide the opportunity to investigate the disease, identify molecular targets for pharmaceutical treatments, and enable the generation of autologous pluripotent stem cell catalogues. Here, we report three patient-derived hiPSC lines carrying the C342Y, S252W or E565G FGFR2 pathogenic variant. The patient hiPSC lines express characteristic pluripotency markers and display distinct phosphorylation profiles under unstimulated conditions. FGFR2C342Y showed autophosphorylation in the absence of bFGF ligand, although downstream docking proteins PLC\u03b3 and FRS2\u03b1 were not phosphorylated. FGFR2S252W and FGFR2E565G hiPSCs showed increased phosphorylation of docking proteins PLC\u03b3 and FRS2\u03b1, whereas FGFR2 was not phosphorylated. These patient hiPSC lines provide molecular and cellular options to investigate FGFR2-linked craniosynostosis in the patient-specific genomic context and develop therapeutic modalities.<\/jats:p>","DOI":"10.1242\/dmm.052123","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T08:51:53Z","timestamp":1755852713000},"source":"Crossref","is-referenced-by-count":0,"title":["Generation of human induced pluripotent stem cell lines from patients with <i>FGFR2<\/i>-linked syndromic craniosynostosis"],"prefix":"10.1242","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8646-814X","authenticated-orcid":false,"given":"Max","family":"Gijsbertsen","sequence":"first","affiliation":[{"name":"Erasmus 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]},{"name":", University Medical Center Rotterdam 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-9922","authenticated-orcid":false,"given":"Irene M. J.","family":"Mathijssen","sequence":"additional","affiliation":[{"name":"Erasmus 2 MC , Department of Plastic and Reconstructive Surgery, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]},{"name":", University Medical Center Rotterdam 2 MC , Department of Plastic and Reconstructive Surgery, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8322-5669","authenticated-orcid":false,"given":"Ana F.","family":"Duarte Madancos","sequence":"additional","affiliation":[{"name":"Erasmus 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]},{"name":", University Medical Center Rotterdam 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]},{"name":"Erasmus 2 MC , Department of Plastic and Reconstructive Surgery, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]},{"name":", University Medical Center Rotterdam 2 MC , Department of Plastic and Reconstructive Surgery, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2282-4006","authenticated-orcid":false,"given":"Johannes P. T. M.","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Erasmus 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]},{"name":", University Medical Center Rotterdam 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6524-727X","authenticated-orcid":false,"given":"Jeroen","family":"van de Peppel","sequence":"additional","affiliation":[{"name":"Erasmus 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]},{"name":", University Medical Center Rotterdam 1 MC , Department of Internal Medicine, Dr. Molewaterplein 40, 3015 GD Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"237","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"2025091802441832600_DMM052123C1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/BJ20071594","article-title":"Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling","volume":"413","author":"Ahmed","year":"2008","journal-title":"Biochem. J."},{"key":"2025091802441832600_DMM052123C2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cellsig.2009.08.011","article-title":"Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function","volume":"22","author":"Ahmed","year":"2010","journal-title":"Cell. Signal."},{"key":"2025091802441832600_DMM052123C3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/biores.2019.0046","article-title":"Induced pluripotent stem cells: reprogramming platforms and applications in cell replacement therapy","volume":"9","author":"Al Abbar","year":"2020","journal-title":"BioRes. Open Access"},{"key":"2025091802441832600_DMM052123C4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/hmg\/7.9.1475","article-title":"Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand","volume":"7","author":"Anderson","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"2025091802441832600_DMM052123C5","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/PRS.0000000000002049","article-title":"Age at the time of surgery and maintenance of head size in nonsyndromic sagittal craniosynostosis","volume":"137","author":"Bergquist","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"2025091802441832600_DMM052123C6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.alcohol.2005.08.001","article-title":"Inhibition of bone repair in a rat model for chronic and excessive alcohol consumption","volume":"36","author":"Chakkalakal","year":"2005","journal-title":"Alcohol. Fayettev. N"},{"key":"2025091802441832600_DMM052123C7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1124\/jpet.106.109454","article-title":"Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts","volume":"319","author":"Chen","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025091802441832600_DMM052123C8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molcel.2007.06.028","article-title":"A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases","volume":"27","author":"Chen","year":"2007","journal-title":"Mol. Cell"},{"key":"2025091802441832600_DMM052123C9","first-page":"5","article-title":"Genetics of craniosynostosis: review of the literature","volume":"2","author":"Ciurea","year":"2009","journal-title":"J. Med. Life"},{"key":"2025091802441832600_DMM052123C10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ajmg.1320470507","article-title":"Sutural biology and the correlates of craniosynostosis","volume":"47","author":"Cohen","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"2025091802441832600_DMM052123C11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/ocr.12153","article-title":"Gene\/environment interactions in craniosynostosis: a brief review","volume":"20","author":"Durham","year":"2017","journal-title":"Orthod. Craniofac. Res."},{"key":"2025091802441832600_DMM052123C12","doi-asserted-by":"publisher","first-page":"18603","DOI":"10.1073\/pnas.0609157103","article-title":"Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis","volume":"103","author":"Eswarakumar","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025091802441832600_DMM052123C13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1042\/BST20180004","article-title":"Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting","volume":"46","author":"Farrell","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"2025091802441832600_DMM052123C14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000492266","article-title":"Genetic causes of craniosynostosis: an update","volume":"10","author":"Goos","year":"2019","journal-title":"Mol. Syndromol."},{"key":"2025091802441832600_DMM052123C15","doi-asserted-by":"publisher","first-page":"27292","DOI":"10.1074\/jbc.M600448200","article-title":"Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F","volume":"281","author":"Hatch","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2025091802441832600_DMM052123C16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet."},{"key":"2025091802441832600_DMM052123C17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3340\/jkns.2016.59.3.192","article-title":"Development and growth of the normal cranial vault: an embryologic review","volume":"59","author":"Jin","year":"2016","journal-title":"J. Korean Neurosurg. Soc."},{"key":"2025091802441832600_DMM052123C18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1086\/338758","article-title":"Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis","volume":"70","author":"Kan","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"2025091802441832600_DMM052123C19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.spen.2007.08.008","article-title":"Genetics of craniosynostosis","volume":"14","author":"Kimonis","year":"2007","journal-title":"Semin. Pediatr. Neurol."},{"key":"2025091802441832600_DMM052123C20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/SCS.0b013e318240c6c0","article-title":"Cranial suture biology: from pathways to patient care","volume":"23","author":"Levi","year":"2012","journal-title":"J. Craniofac. Surg."},{"key":"2025091802441832600_DMM052123C21","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.cell.2012.04.033","article-title":"Inhibition of basal FGF receptor signaling by dimeric Grb2","volume":"149","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"2025091802441832600_DMM052123C22","doi-asserted-by":"publisher","first-page":"292506","DOI":"10.1155\/2013\/292506","article-title":"Craniosynostosis-associated Fgfr2(C342Y) mutant bone marrow stromal cells exhibit cell autonomous abnormalities in osteoblast differentiation and bone formation","volume":"2013","author":"Liu","year":"2013","journal-title":"BioMed Res. Int."},{"key":"2025091802441832600_DMM052123C24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/(SICI)1097-4652(199707)172:1&lt;117::AID-JCP13&gt;3.0.CO;2-9","article-title":"Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2","volume":"172","author":"Mangasarian","year":"1997","journal-title":"J. Cell. Physiol."},{"key":"2025091802441832600_DMM052123C25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1083\/jcb.149.6.1297","article-title":"Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts","volume":"149","author":"Mansukhani","year":"2000","journal-title":"J. Cell Biol."},{"key":"2025091802441832600_DMM052123C26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/BF01660748","article-title":"Craniosynostosis","volume":"13","author":"Marchac","year":"1989","journal-title":"World J. Surg."},{"key":"2025091802441832600_DMM052123C27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/SCS.0000000000007035","article-title":"Updated guideline on treatment and management of craniosynostosis","volume":"32","author":"Mathijssen","year":"2021","journal-title":"J. Craniofac. Surg."},{"key":"2025091802441832600_DMM052123C28","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1074\/jbc.M805432200","article-title":"Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1\/2 and protein kinase C signaling","volume":"284","author":"Miraoui","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025091802441832600_DMM052123C29","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.3390\/ijms22105290","article-title":"Calvaria bone transcriptome in mouse models of osteogenesis imperfecta","volume":"22","author":"Moffatt","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2025091802441832600_DMM052123C49","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1128\/mcb.11.10.5068-5078.1991","article-title":"A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1","volume":"11","author":"Mohammadi","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"2025091802441832600_DMM052123C30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/s0092-8674(00)80131-2","article-title":"Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism","volume":"86","author":"Mohammadi","year":"1996","journal-title":"Cell"},{"key":"2025091802441832600_DMM052123C31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1469-7580.2005.00475.x","article-title":"Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies","volume":"207","author":"Morriss-Kay","year":"2005","journal-title":"J. Anat."},{"key":"2025091802441832600_DMM052123C32","doi-asserted-by":"publisher","first-page":"26037","DOI":"10.1074\/jbc.270.44.26037","article-title":"Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome","volume":"270","author":"Neilson","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2025091802441832600_DMM052123C33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The Fibroblast Growth Factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"2025091802441832600_DMM052123C50","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/358678a0","article-title":"Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis","volume":"358","author":"Peters","year":"1992","journal-title":"Nature"},{"key":"2025091802441832600_DMM052123C34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2134\/agronj2017.10.0580","article-title":"Letters in mean comparisons: what they do and don't mean","volume":"110","author":"Piepho","year":"2018","journal-title":"Agron. J."},{"key":"2025091802441832600_DMM052123C35","doi-asserted-by":"publisher","first-page":"33030","DOI":"10.1074\/jbc.M109.058925","article-title":"N-Glycosylation regulates fibroblast growth factor receptor\/EGL-15 activity in Caenorhabditis elegans in vivo","volume":"284","author":"Polanska","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025091802441832600_DMM052123C36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1597\/1545-1569(2000)037&lt;0433:TCDSCS&gt;2.0.CO;2","article-title":"The craniofacial dysostosis syndromes: current surgical thinking and future directions","volume":"37","author":"Posnick","year":"2000","journal-title":"Cleft Palate-Craniofacial J."},{"key":"2025091802441832600_DMM052123C37","doi-asserted-by":"publisher","first-page":"e1630","DOI":"10.1002\/wsbm.1630","article-title":"iPSCs as a groundbreaking tool for the study of adverse drug reactions: a new avenue for personalized therapy","volume":"16","author":"Rispoli","year":"2024","journal-title":"WIREs Mech. Dis."},{"key":"2025091802441832600_DMM052123C38","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1073\/pnas.0913985107","article-title":"Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate","volume":"107","author":"Snyder-Warwick","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025091802441832600_DMM052123C39","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1002\/jcp.24021","article-title":"Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts","volume":"227","author":"Suzuki","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"2025091802441832600_DMM052123C40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nsmb.2752","article-title":"Competition between Grb2 and Plc\u03b31 for FGFR2 regulates basal phospholipase activity and invasion","volume":"21","author":"Timsah","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2025091802441832600_DMM052123C41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/genes14030615","article-title":"Review of recurrently mutated genes in craniosynostosis supports expansion of diagnostic gene panels","volume":"14","author":"Tooze","year":"2023","journal-title":"Genes"},{"key":"2025091802441832600_DMM052123C42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ajhg.2015.07.006","article-title":"A genetic-pathophysiological framework for craniosynostosis","volume":"97","author":"Twigg","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"2025091802441832600_DMM052123C43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12015-011-9279-x","article-title":"Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine","volume":"8","author":"Walia","year":"2012","journal-title":"Stem Cell Rev. Rep."},{"key":"2025091802441832600_DMM052123C44","article-title":"FGFR craniosynostosis syndromes overview","volume-title":"GeneReviews\u00ae","author":"Wenger","year":"1993"},{"key":"2025091802441832600_DMM052123C45","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/hmg\/6.10.1647","article-title":"Craniosynostosis: genes and mechanisms","volume":"6","author":"Wilkie","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"2025091802441832600_DMM052123C46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/s0960-9822(95)00102-3","article-title":"Functions of fibroblast growth factors and their receptors","volume":"5","author":"Wilkie","year":"1995","journal-title":"Curr. Biol."},{"key":"2025091802441832600_DMM052123C47","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/MOP.0000000000000542","article-title":"Clinical genetics of craniosynostosis","volume":"29","author":"Wilkie","year":"2017","journal-title":"Curr. Opin. Pediatr."},{"key":"2025091802441832600_DMM052123C48","doi-asserted-by":"publisher","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","article-title":"Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome","volume":"97","author":"Yu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052123\/3662256\/dmm052123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052123\/3665797\/dmm052123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052123\/3665797\/dmm052123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T06:44:24Z","timestamp":1758177864000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/18\/10\/dmm052123\/369201\/Generation-of-human-induced-pluripotent-stem-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.052123","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"type":"print","value":"1754-8403"},{"type":"electronic","value":"1754-8411"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"dmm052123"}}